title: Rhythm control in heart failure patients with atrial fibrillation: contemporary challenges including the role of ablation.
abstract: Because nonpharmacological interventions likely alter the risks and benefits associated with rhythm control, this paper reviews the role of current rhythm control strategies in atrial fibrillation. This report also focuses on the specific limitations of pharmacological interventions and the utility of percutaneous ablation in this growing population of patients with concomitant atrial fibrillation and heart failure.
authors.affiliation: Duke Center for Atrial Fibrillation, Duke University Medical Center, Durham, North Carolina.
authors.forename: Kevin M
authors.initials: KM
authors.lastname: Trulock
authors.affiliation: Cardiology Division, University of California San Diego, San Diego, California.
authors.forename: Sanjiv M
authors.initials: SM
authors.lastname: Narayan
authors.affiliation: Duke Center for Atrial Fibrillation, Duke University Medical Center, Durham, North Carolina. Electronic address: jonathan.piccini@duke.edu.
authors.forename: Jonathan P
authors.initials: JP
authors.lastname: Piccini
mesh_terms: D000889:Anti-Arrhythmia Agents / Q000627:therapeutic use*; D001281:Atrial Fibrillation / Q000150:complications / Q000503:physiopathology / Q000628:therapy; D017115:Catheter Ablation / Q000379:methods*; D004562:Electrocardiography / Q000379:methods*; D006333:Heart Failure / Q000150:complications / Q000503:physiopathology / Q000628:therapy; D006339:Heart Rate / Q000502:physiology*; D006801:Humans; D016896:Treatment Outcome
chemical_list: D000889:Anti-Arrhythmia Agents
keywords: antiarrhythmic drug therapy; atrial fibrillation; catheter ablation; heart failure; rhythm control